Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 1/20 | 0.58 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.58 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.58 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.58 |
| ▸ | ST6GAL1 | P15907 | 9/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27938161 | 1.00 | NT5E (0.68) | NT5ELMNATHRBMTORMDM2 | |
| Phosphoric Acid SCHEMBL16859831 | 0.87 | NT5E (0.67) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL28822178 | 0.87 | NT5E (0.53) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL28822175 | 0.87 | NT5E (0.53) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL3789915 | 0.85 | NT5E (0.64) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL1763223 | 0.85 | NT5E (0.64) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL1763085 | 0.85 | NT5E (0.64) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL4414290 | 0.85 | NT5E (0.67) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL223209 | 0.84 | NT5E (0.65) | NT5ELMNATHRBMTORMDM2 | |
| SCHEMBL13134657 | 0.84 | NT5E (0.65) | NT5ELMNATHRBMTORMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104395480-A | Methods and compositions for size-controlled homopolymer tailing of substrate polynucleotides by nucleic acid polymerases | SWIFT BIOSCIENCES INC | 2015-03-04 | — | — | CN | claimed |
| EP-4114547-A2 | METHODS OF MAKING HYPER-SIALYLATED IMMUNOGLOBULIN | Momenta Pharmaceuticals, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| WO-2021178682-A2 | METHODS OF MAKING HYPER-SIALYLATED IMMUNOGLOBULIN | MOMENTA PHARMACEUTICALS, INC. (US) | 2021-09-10 | — | — | WO | disclosed |
| WO-2018115309-A1 | PREPARATION OF SUGAR-NUCLEOTIDES | NOVO NORDISK A/S (DK) | 2018-06-28 | — | — | WO | disclosed |
| EP-3337488-A1 | TREATMENT AND PREVENTION OF NEISSERIA GONORRHOEAE INFECTION USING CMP-ACTIVATED NONULOSONATE ANALOG COMPOUNDS | National Research Council of Canada (CA) | 2018-06-27 | — | — | EP | disclosed |
| WO-2017027980-A1 | TREATMENT AND PREVENTION OF NEISSERIA GONORRHOEAE INFECTION USING CMP-ACTIVATED NONULOSONATE ANALOG COMPOUNDS | NATIONAL RESEARCH COUNCIL CANADA (CA) | 2017-02-23 | — | — | WO | disclosed |
| CN-103338775-B | Methods of using human milk oligosaccharides to reduce the incidence of necrotizing enterocolitis in infants, toddlers, or children | ABBOTT LABORATORIES (US) | 2016-11-30 | — | — | CN | disclosed |
| CN-106011310-A | Method for amplifying and/or detecting nucleic acids, kits and uses of said method | 生物梅里埃公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-105007758-A | Low-buffer nutritional composition and uses thereof | MJN US HOLDINGS LLC | 2015-10-28 | — | — | CN | disclosed |
| CN-104395480-A | Methods and compositions for size-controlled homopolymer tailing of substrate polynucleotides by nucleic acid polymerases | SWIFT BIOSCIENCES INC | 2015-03-04 | — | — | CN | disclosed |
| CN-104126749-A | Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk | NESTEC SA | 2014-11-05 | — | — | CN | disclosed |
| CN-103929980-A | Infant formula with high SN-2 palmitate and oligofructose | NESTEC SA | 2014-07-16 | — | — | CN | disclosed |
| CN-103338775-A | Methods of using human milk oligosaccharides to reduce the incidence of necrotizing enterocolitis in infants, toddlers, or children | ABBOTT LAB | 2013-10-02 | — | — | CN | disclosed |
| EP-0640835-B1 | Method for determining sugar chain structure | TAKARA BIO INC (JP) | 2004-04-07 | — | — | EP | disclosed |
| EP-0640835-A2 | Method for determining sugar chain structure | TAKARA SHUZO CO. LTD. (JP) | 1995-03-01 | — | — | EP | disclosed |